Sep 28, 2009 | Business Standard
In a development that would enable better and more affordable treatment for HIV/AIDS patients on second-line antiretroviral therapy in the developing world, the Clinton HIV/AIDS Initiative , Mylan Inc and Hyderabad-based Matrix Laboratories have signed an agreement to offer a once-daily dose of the second-line regimen of four ARVs for under $500 ...
Teacher Leadership Institutes held at lush hotel
More than 600 state teachers got to live large this summer during two weeklong Teacher Leadership Institutes hosted by the state Department of Education at the luxurious Waterfront Place Hotel in Morgantown.
S&P upgrades Mylan ratings on improved performance
Standard & Poor's said Wednesday it raised the corporate credit rating on Mylan Inc.
Will Teva Be Forced to Take Its Own Medicine?
Judging from the success of Teva Pharmaceutical Industries , you might say the most exalted employees are the lawyers who find ways to crack the patents of other drugmakers' products.
FDA Warning: Stay Away From Stolen Respiratory Meds
The U.S. Food and Drug Administration is advising consumers not to use certain respiratory medications made by Canonsburg-based Mylan, Inc.
Tevaa s Copaxone Challenged by Mylan
Shares of generic player Teva Pharmaceuticals, Inc. were down approximately 2% on news regarding the acceptance of an abbreviated new drug application for its multiple sclerosis drug, Copaxone.
FDA warns on respiratory meds stolen
The U.S. Food and Drug Administration advised consumers not to use certain respiratory medications.
FDA tentatively approvals Matrix Labs' combination antiretroviral product
PITTSBURGH A subsidiary of a generic drug maker has received tentative approval from the Food and Drug Administration under Pres.
Dey Issues Advisory Regarding Stolen Respiratory Medications
Dey L.P., a subsidiary of Mylan Inc. , today issued an advisory regarding the theft of two different types of its respiratory medications, Ipratropium Bromide Inhalation Solution, 0.02%, and Albuterol Sulfate Inhalation Solution, 0.083%, unit-dose vials.
Customer Interaction Solutions
www.PicksThatMove.com: 'Picks that move' Alerts, September 14, 2009:...
September 14, 2009 Mylan Inc. trading at $15.24 on a volume of 1.93M shares. In a press release out on September 14, 2009 FDA Accepts for Filing Mylan's ANDA for Generic Copaxone PITTSBURGH, Sept 14, 2009 -- Mylan Inc.
Israel Stocks: Israel slumps; Teva may face Mylan challenge
Israeli stocks were broadly lower Monday, reflecting weakness in all sectors but particularly in real estate and banking.
Photographer Annie Leibovitz's loan repayment due
User Sign In Sign in now to: Personalize the content, colors, and layout of your page Choose news headlines, stock quotes, and the weather in your neighborhood Display all the links and information you need in one place Have fun! Over 50 games to play, plus My eBay and My Theaters features-all with no pop-ups! Photographer Annie Leibovitz's loan ...
Convertible Securities On The Right Track
Convertible bonds and preferred shares are among the lesser known securities available to investors.
Influential Morgantown Businessman Speaks to Professionals and Students
One of Morgantown's most prestigious businessmen spoke at the Waterfront Place Hotel this evening about capitalism and the importance of following your dreams.
Mylan Inc. Says Parting Ways with Recently Hired CFO
Mylan Inc. today announced its decision to part ways with its chief financial officer.
Biotech Stocks: Drug stocks edge higher; Vivus rockets
Drug stocks edged higher in early action Wednesday as shares of Vivus Inc. rocketed on positive late-stage clinical data for its weight-loss drug Qnexa.
Michael Feinstein plans a return to Broadway
User Sign In Sign in now to: Personalize the content, colors, and layout of your page Choose news headlines, stock quotes, and the weather in your neighborhood Display all the links and information you need in one place Have fun! Over 50 games to play, plus My eBay and My Theaters features-all with no pop-ups! Michael Feinstein plans a return to ...
Mark W. Parrish Joins Mylan's Board of Directors
Mylan Inc. today announced that Mark W. Parrish, chairman and CEO of Trident USA Health Services, the nation's largest provider of mobile X-ray and laboratory services to the long-term care industry, has joined Mylan's Board of Directors.
Tuesday's Tidalwaves!!! $$$$ - (NASDAQ: FUEL) SMF Energy Corp.,...
Tuesday's Tidalwaves!!! $$$$ - SMF Energy Corp., Mylan, Inc., Orbit International Corp., Sirius XM Radio, Inc., NavStar Technologies, Inc.
The first 100 days in office sets the tone for any new president. Similarly, Motley Fool CAPS keeps an eye on how well investors do in their first 100 days.
Mylan's subsidiary launches levalbuterol inhalation solution used for treating bronchospasm
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched levalbuterol inhalation solution USP , 0.25%, . Mylan, which has already launched the product, will market this product with 180 days of exclusivity.
Also on Topix